BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23900758)

  • 1. RFLP readout introduces a type I error in meta-analysis of IL-6.
    Sand PG
    J Neurol; 2013 Sep; 260(9):2423. PubMed ID: 23900758
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer's disease: a meta-analysis.
    Dai L; Liu D; Guo H; Wang Y; Bai Y
    J Neurol; 2012 Mar; 259(3):414-9. PubMed ID: 21748280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 genotype and the susceptibility to Alzheimer's disease.
    Sand PG
    Int J Neurosci; 2015; 125(12):959-60. PubMed ID: 25405532
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between tumor necrosis factor-α promoter -308 A/G, -238 A/G, interleukin-6 -174 G/C and -572 G/C polymorphisms and periodontal disease: a meta-analysis.
    Song GG; Choi SJ; Ji JD; Lee YH
    Mol Biol Rep; 2013 Aug; 40(8):5191-203. PubMed ID: 23657600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
    Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
    Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 promoter polymorphism at position -174 in biopsy-proven patients with erythema nodosum from a defined population.
    Amoli MM; Miranda-Filloy JA; Fernandez-Diaz ML; Martin J; Ollier WE; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S155-6. PubMed ID: 18799077
    [No Abstract]   [Full Text] [Related]  

  • 7. Promoter polymorphisms in IL-6 gene influence pro-inflammatory cytokines for the risk of osteoarthritis.
    Singh M; Mastana S; Singh S; Juneja PK; Kaur T; Singh P
    Cytokine; 2020 Mar; 127():154985. PubMed ID: 31951965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected].
    Pola R; Flex A; Gaetani E; Lago AD; Gerardino L; Pola P; Bernabei R
    Neuroreport; 2002 Sep; 13(13):1645-7. PubMed ID: 12352619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The -174/-597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis.
    Fedetz M; Matesanz F; Pascual M; Martín J; Fernández O; Guerrero M; Alcina A
    J Neurol Sci; 2001 Sep; 190(1-2):69-72. PubMed ID: 11574109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between polymorphisms of interleukin-6 gene promoter and breast cancer].
    He KL; Li YP; Lv YG; Zhang DJ; Wang H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1220-2. PubMed ID: 22078452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has dysregulated interleukin-6 gene a role in the development of Alzheimer's disease?
    Capurso C
    Neurosci Lett; 2011 Oct; 504(1):1-3. PubMed ID: 21889969
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk.
    Faltraco F; Bürger K; Zill P; Teipel SJ; Möller HJ; Hampel H; Bondy B; Ackenheil M
    J Am Geriatr Soc; 2003 Apr; 51(4):578-9. PubMed ID: 12657090
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases.
    Shibata N; Ohnuma T; Takahashi T; Baba H; Ishizuka T; Ohtsuka M; Ueki A; Nagao M; Arai H
    Am J Med Genet; 2002 May; 114(4):436-9. PubMed ID: 11992567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a single nucleotide polymorphism in the IL-6 promoter region of ancient nuclear DNA.
    Larcombe LA; Nickerson P; Hoppa RD; Matheson C
    Infect Genet Evol; 2005 Mar; 5(2):117-22. PubMed ID: 15639743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of interleukin-10-1082 promoter polymorphism with gastric cancer: appraisal of a recent meta-analysis.
    Wang F; Sun G; Zou Y
    DNA Cell Biol; 2012 May; 31(5):646-7; author reply 648-50. PubMed ID: 22612319
    [No Abstract]   [Full Text] [Related]  

  • 18. IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris.
    Baran W; Szepietowski JC; Mazur G; Baran E
    Acta Derm Venereol; 2008; 88(2):113-6. PubMed ID: 18311435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism 174 G/C of interleukin 6 gene in Alzheimer's disease--preliminary report.
    Paradowski B; Celczyńska D; Dobosz T; Noga L
    Neurol Neurochir Pol; 2008; 42(4):312-5. PubMed ID: 18975235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. - 174 G>C IL-6 polymorphism and primary iron overload in male patients.
    Tetzlaff WF; Meroño T; Botta EE; Martín ME; Sorroche PB; Boero LE; Castro M; Frechtel GD; Rey J; Daruich J; Cerrone GE; Brites F
    Ann Hematol; 2018 Sep; 97(9):1683-1687. PubMed ID: 29656314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.